PARP inhibition in UV-associated angiosarcoma preclinical models

PURPOSE: Angiosarcoma (AS) is a rare vasoformative sarcoma, with poor overall survival and a high need for novel treatment options. Clinically, AS consists of different subtypes, including AS related to previous UV exposure (UV AS) which could indicate susceptibility to DNA damage repair inhibition....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cancer Res Clin Oncol
Päätekijät: Weidema, Marije E., Desar, Ingrid M. E., Hillebrandt-Roeffen, Melissa H. S., van Erp, Anke E. M., Masuzawa, Mikio, Flucke, Uta E., van der Graaf, Winette T. A., Versleijen-Jonkers, Yvonne M. H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2021
Aiheet:
Original Article – Cancer Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310857/
https://ncbi.nlm.nih.gov/pubmed/34085099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-021-03678-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia